A Yakubu

Publications (3)7.58 Total impact

• Article: Cutaneonephrobronchial fistula: an unusual presentation of an inadequately treated perinephric abscess.

  N K Saw, A Yakubu, P M Woodhead
  [show abstract] [hide abstract]
  ABSTRACT: We report a case of cutaneonephrobronchial fistula secondary to an inadequately treated perinephric abscess associated with a staghorn calculus. The patient, a 72-year-old lady, was initially treated for a superficial flank abscess by incision and drainage. She returned 4 months later with a persistent discharging flank sinus, at which time the above complex pathology was diagnosed. We review similar cases in the literature and discuss pathophysiology and current management of perinephric abscesses.
  Urologia Internationalis 02/2007; 78(3):280-2. · 0.99 Impact Factor
• Article: Extensive urethral stricture after using mitomycin in local anaesthetic jelly for urethral tumours.

  A Yakubu, P M Salanki, M Cade, D G Barnes
  BJU International 06/1999; 83(7):873-4. · 2.84 Impact Factor
• Article: Catheter-free endoscopic laser ablation of the prostate using a 1-size prostatic stent.

  A Yakubu, D G Barnes
  [show abstract] [hide abstract]
  ABSTRACT: Endoscopic laser ablation of the prostate is a safe alternative to transurethral prostatic resection. Recognized disadvantages include prolonged catheterization, postoperative discomfort and delayed symptomatic improvement. We assessed the role of a 1-size temporary prostatic stent in men undergoing endoscopic laser ablation of the prostate. A total of 55 men a mean of 73 years old with outflow obstruction, including 9 who presented in urinary retention, underwent endoscopic laser ablation of the prostate and temporary stenting. Urinary flow rate, residual urine volume, symptom score and prostate specific antigen were measured preoperatively, and 6 weeks (with the stent in situ), 3 months (after stent removal) and 12 months postoperatively. Duration of hospital stay and complications were also recorded. Of the 55 men 37 (67%) voided immediately with the stent in situ, including 7 of the 9 in retention. At 6 weeks with the stent in place mean maximum urine flow was 17.3 ml. per second (preoperatively 8.7). Dysuria was reported by 3 patients. Stent related complications were rare. One stent migrated early, resulting in urinary retention, while 2 that migrated late were asymptomatic. No patient had acute urinary retention after stent removal. Maximum urinary flow rate measured at 6 weeks with the stent in situ was similar to that 1 year after endoscopic laser ablation of the prostate. The use of a 1-size, inexpensive plastic prostatic stent enabled catheter-free endoscopic laser ablation of the prostate in 67% of our patients. Early improvements in the urinary flow rate and a lower incidence of dysuria were additional benefits. The result of endoscopic laser ablation of the prostate at 1 year was comparable to that of transurethral prostatic resection.
  The Journal of Urology 07/1998; 159(6):1974-7. · 3.75 Impact Factor